RIL
GOSS icon

Rothschild Investment LLC’s Gossamer Bio GOSS Stock Holding History

Rothschild Investment LLC’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262 Sell
20
-5
-20% -$112 ﹤0.01% 3402
2026
Q1 		$661 Buy
25
+22
+733% +$2.77K ﹤0.01% 3026
2025
Q4 		$784 Buy
+3
New +$685 ﹤0.01% 2762

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.27% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Rothschild Investment LLC's GOSS Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Gossamer Bio (GOSS) stake by 20% in Q2 2026, selling an estimated $112 and leaving 20 shares worth $262. The position accounts for ﹤0.01% of the portfolio, ranked #3402.

Rothschild Investment LLC first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $784 in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Rothschild Investment LLC held 20 shares of Gossamer Bio worth $262 as of Q2 2026.
  • Rothschild Investment LLC sold 5 Gossamer Bio shares in Q2 2026, an estimated $112.
  • Gossamer Bio made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3402 holding.
  • Rothschild Investment LLC first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • Rothschild Investment LLC's Gossamer Bio position peaked at $784 in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.